Chemoinformaics analysis of BENZENE, 1-METHYL-4-(2-METHYLPROPYL)-
| Molecular Weight | 148.249 | nRot | 2 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 6 |
| Exact Molecular Weight | 148.125 | nRing | 1 |
| Solubility: LogS | -4.707 | nHRing | 0 |
| Solubility: LogP | 4.401 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 0 | APOL | 29.0387 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.604 |
| Synth | 1.323 |
| Natural Product Likeliness | -0.405 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.005 |
| HIA | 0.003 |
| CACO-2 | -4.297 |
| MDCK | 0.0000236 |
| BBB | 0.861 |
| PPB | 0.937237 |
| VDSS | 2.17 |
| FU | 0.0545349 |
| CYP1A2-inh | 0.845 |
| CYP1A2-sub | 0.835 |
| CYP2c19-inh | 0.924 |
| CYP2c19-sub | 0.838 |
| CYP2c9-inh | 0.816 |
| CYP2c9-sub | 0.913 |
| CYP2d6-inh | 0.074 |
| CYP2d6-sub | 0.397 |
| CYP3a4-inh | 0.103 |
| CYP3a4-sub | 0.488 |
| CL | 11.955 |
| T12 | 0.339 |
| hERG | 0.054 |
| Ames | 0.015 |
| ROA | 0.037 |
| SkinSen | 0.294 |
| Carcinogencity | 0.477 |
| EI | 0.991 |
| Respiratory | 0.037 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.796554 |